Tandem Labs is a bioanalytical and immunoanalytical contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs.
The sale of Tandem Labs generated approximately a return of 6.9 times the invested capital for DW Healthcare’s investors.